Vicarious Surgical Stock EBITDA
| RBOT Stock | USD 5.85 0.13 2.17% |
Vicarious Surgical's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Vicarious Stock price.
| Last Reported | Projected for Next Year | ||
| EBITDA | -61.1 M | -64.2 M |
Vicarious | EBITDA | Build AI portfolio with Vicarious Stock |
Vicarious Surgical Company EBITDA Analysis
Vicarious Surgical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Vicarious Surgical EBITDA | (61.12 M) |
Most of Vicarious Surgical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vicarious Surgical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vicarious EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Vicarious Surgical is extremely important. It helps to project a fair market value of Vicarious Stock properly, considering its historical fundamentals such as EBITDA. Since Vicarious Surgical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vicarious Surgical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vicarious Surgical's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Vicarious Ebitda
Ebitda |
|
According to the company disclosure, Vicarious Surgical reported earnings before interest,tax, depreciation and amortization of (61.12 Million). This is 106.97% lower than that of the Health Care Equipment & Supplies sector and 109.51% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.57% higher than that of the company.
Vicarious EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vicarious Surgical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vicarious Surgical could also be used in its relative valuation, which is a method of valuing Vicarious Surgical by comparing valuation metrics of similar companies.Vicarious Surgical is currently under evaluation in ebitda category among its peers.
Vicarious Surgical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vicarious Surgical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vicarious Surgical's managers, analysts, and investors.Environmental | Governance | Social |
Vicarious Surgical Institutional Holders
Institutional Holdings refers to the ownership stake in Vicarious Surgical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vicarious Surgical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vicarious Surgical's value.| Shares | Dimensional Fund Advisors, Inc. | 2025-06-30 | 16.4 K | Bridgeway Capital Management, Llc | 2025-06-30 | 11.8 K | Renaissance Technologies Corp | 2025-06-30 | 11.1 K | Royal Bank Of Canada | 2025-06-30 | 5.1 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.8 K | Advisor Group Holdings, Inc. | 2025-06-30 | 1.6 K | Hanson Mcclain Inc | 2025-06-30 | 1 K | Hughes Financial Services, Llc | 2025-06-30 | 333 | Future Financial Wealth Managment Llc | 2025-06-30 | 210 | Vk Services Llc | 2025-06-30 | 965.2 K | Ddd Partners, Llc | 2025-06-30 | 207.1 K |
Vicarious Fundamentals
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | 22.27 M | ||||
| Shares Outstanding | 5.89 M | ||||
| Shares Owned By Insiders | 20.30 % | ||||
| Shares Owned By Institutions | 30.32 % | ||||
| Number Of Shares Shorted | 143.31 K | ||||
| Price To Earning | 8.61 X | ||||
| Price To Book | 1.43 X | ||||
| EBITDA | (61.12 M) | ||||
| Net Income | (63.22 M) | ||||
| Cash And Equivalents | 126.8 M | ||||
| Cash Per Share | 1.04 X | ||||
| Total Debt | 13.79 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 11.25 X | ||||
| Book Value Per Share | 3.88 X | ||||
| Cash Flow From Operations | (49.96 M) | ||||
| Short Ratio | 1.39 X | ||||
| Earnings Per Share | (10.07) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 121 | ||||
| Beta | 1.39 | ||||
| Market Capitalization | 38.31 M | ||||
| Total Asset | 67.72 M | ||||
| Retained Earnings | (195.94 M) | ||||
| Working Capital | 44.03 M | ||||
| Net Asset | 67.72 M |
About Vicarious Surgical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vicarious Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vicarious Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vicarious Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.